Generic Phenytoin 100mg Immediate-Release Tablets
Immediate-release tablets containing 100mg phenytoin for rapid absorption in acute seizure control. Classified in HTS 3004.90.92.39 for its role as a sedative-hypnotic anticonvulsant with phenytoin, in retail measured doses.
Import Duty Rates by Country of Origin
Alternative Classifications
This product could be classified differently depending on its characteristics or intended use.
If formulated as different anticonvulsant like valproate
Specific active ingredient phenytoin defines this subheading; others use adjacent codes.
If pure phenytoin API without dosage form
Active pharmaceutical ingredients without retail medicaments packaging classified as heterocyclics.
Not sure which classification is right?
Our AI classifier can analyze your specific product and recommend the correct HTS code with confidence.
Import Tips & Compliance
• Include bioequivalence studies comparing to reference Dilantin for ANDA validation
• Label with 'immediate-release' to distinguish from extended-release for proper duty assessment
• Ensure tamper-evident seals mandatory for tablet retail packaging
Related Products under HTS 3004.90.92.39
Phenytoin Sodium Extended-Release Capsules 100mg
These extended-release capsules contain 100mg of phenytoin sodium, an anticonvulsant used to control seizures in epilepsy patients. Classified under HTS 3004.90.92.39 as a mixed or unmixed medicament in measured doses for therapeutic use, primarily affecting the central nervous system as an anticonvulsant containing phenytoin salts.
Dilantin 30mg Chewable Tablets
Dilantin chewable tablets with 30mg phenytoin sodium are designed for pediatric epilepsy patients who have difficulty swallowing capsules. This product falls under HTS 3004.90.92.39 due to its phenytoin salt content, measured dosing, and retail packaging for central nervous system anticonvulsant therapy.
Phenytoin Sodium 50mg/5ml Oral Suspension
This liquid oral suspension delivers 50mg phenytoin sodium per 5ml dose, ideal for patients requiring adjustable dosing for seizure management. It qualifies for HTS 3004.90.92.39 as a therapeutic anticonvulsant in measured form containing phenytoin salts, put up for retail sale.
Phenytoin Sodium 200mg Extended-Release Tablets
High-strength 200mg extended-release tablets of phenytoin sodium for once-daily dosing in chronic epilepsy treatment. Meets HTS 3004.90.92.39 criteria as a CNS anticonvulsant containing phenytoin salts in measured retail doses.
Epilexil Phenytoin 125mg/5ml Pediatric Suspension
Epilexil brand pediatric suspension with 125mg phenytoin per 5ml for infant seizure prophylaxis. Falls under HTS 3004.90.92.39 as a prophylactic anticonvulsant containing phenytoin salts in measured liquid doses for retail.
Phenytoin Sodium 300mg Extended-Release Capsules
Maximum strength 300mg extended-release phenytoin capsules for severe epilepsy management. Classified HTS 3004.90.92.39 for phenytoin salt content as CNS anticonvulsant in retail measured form.